Cargando…
Transformation of HHV‐8‐negative idiopathic multicentric Castleman disease into diffuse large B‐cell lymphoma: A case report from Nepal
KEY CLINICAL MESSAGE: Idiopathic Castleman disease transforming into Diffuse Large B‐cell Lymphoma has an aggressive course and can lead to mortality. Hence, early diagnosis and intervention are required. ABSTRACT: Idiopathic Castleman disease transforming into non‐Hodgkin lymphoma has an aggressive...
Autores principales: | Gupta, Ashwini, Anand, Ayush, Hussain, Salman Haidar, Shah, Raju, Ranjan, Rajesh, Subedi, Viplaw, Baral, Aastha, Mishra, Akshat, Pradhan, Anju, Dulal, Soniya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495613/ https://www.ncbi.nlm.nih.gov/pubmed/37705586 http://dx.doi.org/10.1002/ccr3.7903 |
Ejemplares similares
-
Leukemoid reaction in a patient with metastatic renal cell carcinoma—rare clinical presentation seen in Nepal: a case report
por: Khatiwada, Pramit, et al.
Publicado: (2023) -
Steroids/tacrolimus: HHV-8 related multicentric Castleman disease : case report
Publicado: (2021) -
HHV-8-negative multicentric Castleman disease presenting as a crescentic immune complexes membranoproliferative glomerulonephritis
por: Nunes, Maria Brito, et al.
Publicado: (2020) -
Are Patients with HHV-8 Associated Castleman Disease Successfully Treated with Rituximab at Risk of Subsequently Developing HHV-8 Negative (Idiopathic) Castleman Disease?
por: Ha, Gavin, et al.
Publicado: (2023) -
Higher rate of progression in HIV(–) than in HIV(+) patients after rituximab for HHV8(+) multicentric Castleman disease
por: Rasmussen, Camille, et al.
Publicado: (2023)